Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

IgV H Germline and Mutated Chronic Lymphocytic Leukemia (CLL) Cases Exert a Diverse Responsiveness upon BCR Ligation.

Simona Tavolaro, BS, Roberta Maggio, BS, Nadia Peragine, BS, Monica Messina, BS, Franca Citarella, PhD, Simona Santangelo Miss, Marilisa Marinelli, BS, Maria R. Ricciardi, PhD, Maria S. De Propris, PhD, Ilaria Del Giudice, MD, PhD, Francesca R. Mauro, MD, Sabina Chiaretti, MD, PhD, Robert Foa, MD, Anna Guarini, PhD

Blood (2007) 110 (11): 1133.

https://doi.org/10.1182/blood.V110.11.1133.1133

Published: 2007

Journal Articles

T Regulatory Cells Obtained from Cord Blood Are Greatly Expandable and Exert Potent Suppressive Function.

Giovanni F. Torelli, MD, PhD, Roberta Maggio, BS, Nadia Peragine, BS, Barbarella Lucarelli, MD, Maria S. De Propris, PhD, Maria Screnci, MD, Simona Salvatori, BS, Anna P. Iori, MD, PhD, Filippo Milano, MD, Veronica Valle, MD, Emilia Iannella, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2007) 110 (11): 4862.

https://doi.org/10.1182/blood.V110.11.4862.4862

Published: 2007

Journal Articles

Gene Expression Profile Reveals a Unique Pattern of Protein Kinases in Chronic Lymphocytic Leukemia (CLL): Potential Role of the Second Generation Protein Kinase Inhibitors.

Simona Tavolaro, BS, Sabina Chiaretti, MD, PhD, Monica Messina, BS, Nadia Peragine, BS, Roberta Maggio, BS, Ilaria Del Giudice, MD, PhD, Emanuela M. Ghia, PhD, Francesca R. Mauro, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2007) 110 (11): 3117.

https://doi.org/10.1182/blood.V110.11.3117.3117

Published: 2007

Journal Articles

Gene Expression Profile of Protein Kinases Reveals a Distinctive Signature of Chronic Lymphocytic Leukemia (CLL) and Points to a Role of Second Generation Protein Kinase Inhibitors.

Simona Tavolaro, BS, Sabina Chiaretti, MD, PhD, Monica Messina, BS, Francesca R. Mauro, MD, Ilaria Del Giudice, MD PhD, Roberta Maggio, BS, Emanuela M. Ghia, BS, Marilisa Marinelli, BS, Simona Santangelo Miss, Anna Guarini, PhD, Robert Foa, MD

Blood (2006) 108 (11): 2794.

https://doi.org/10.1182/blood.V108.11.2794.2794

Published: 2006

Journal Articles

The MicroRNA (miR) Profile in B-Cell Chronic Lymphocytic Leukemia (CLL) Reveals a Differential Expression of miR-21, miR-155 and miR-150 between Leukemic and Normal B Lymphocytes, and of miR-150, miR-29bc and miR-223 between IgV H Mutated and Unmutated Patients.

Sabina Chiaretti, MD, PhD, Valerio Fulci, PhD, Marina Goldoni, BS, Gianluca Azzalin, Mr, Simona Tavolaro, BS, Monica Messina, BS, Roberta Maggio, BS, Nadia Peragine, BS, Simona Santangelo Miss, Francesca R. Mauro, MD, Anna Guarini, PhD, Giuseppe Macino, PhD, Robert Foa, MD

Blood (2006) 108 (11): 298.

https://doi.org/10.1182/blood.V108.11.298.298

Published: 2006

Journal Articles

Angiogenic Activity in IgV H Mutated and Unmutated Chronic Lymphocytic Leukemia (CLL): Indications for the Therapeutic Use of VEGF-Signaling Inhibitors.

Roberta Maggio, BS, Nadia Peragine, BS, Monica Messina, BS, Sabina Chiaretti, MD PhD, Stefania M. De Propris, PhD, Simona Tavolaro, BS, Marilisa Marinelli, BS, Elisabetta Calabrese, BS, Ilaria Del Giudice, MD PhD, Francesca R. Mauro, MD, Anna Guarini, PhD, Robert Foa, MD

Blood (2006) 108 (11): 2819.

https://doi.org/10.1182/blood.V108.11.2819.2819

Published: 2006

NARROW

IgV H Germline and Mutated Chronic Lymphocytic Leukemia (CLL) Cases Exert a Diverse Responsiveness upon BCR Ligation.

T Regulatory Cells Obtained from Cord Blood Are Greatly Expandable and Exert Potent Suppressive Function.

Gene Expression Profile Reveals a Unique Pattern of Protein Kinases in Chronic Lymphocytic Leukemia (CLL): Potential Role of the Second Generation Protein Kinase Inhibitors.

Gene Expression Profile of Protein Kinases Reveals a Distinctive Signature of Chronic Lymphocytic Leukemia (CLL) and Points to a Role of Second Generation Protein Kinase Inhibitors.

The MicroRNA (miR) Profile in B-Cell Chronic Lymphocytic Leukemia (CLL) Reveals a Differential Expression of miR-21, miR-155 and miR-150 between Leukemic and Normal B Lymphocytes, and of miR-150, miR-29bc and miR-223 between IgV H Mutated and Unmutated Patients.

Angiogenic Activity in IgV H Mutated and Unmutated Chronic Lymphocytic Leukemia (CLL): Indications for the Therapeutic Use of VEGF-Signaling Inhibitors.

Email alerts

ASH Publications

American Society of Hematology

IgV H Germline and Mutated Chronic Lymphocytic Leukemia (CLL) Cases Exert a Diverse Responsiveness upon BCR Ligation.

T Regulatory Cells Obtained from Cord Blood Are Greatly Expandable and Exert Potent Suppressive Function.

Gene Expression Profile Reveals a Unique Pattern of Protein Kinases in Chronic Lymphocytic Leukemia (CLL): Potential Role of the Second Generation Protein Kinase Inhibitors.

Gene Expression Profile of Protein Kinases Reveals a Distinctive Signature of Chronic Lymphocytic Leukemia (CLL) and Points to a Role of Second Generation Protein Kinase Inhibitors.

The MicroRNA (miR) Profile in B-Cell Chronic Lymphocytic Leukemia (CLL) Reveals a Differential Expression of miR-21, miR-155 and miR-150 between Leukemic and Normal B Lymphocytes, and of miR-150, miR-29bc and miR-223 between IgV H Mutated and Unmutated Patients.

Angiogenic Activity in IgV H Mutated and Unmutated Chronic Lymphocytic Leukemia (CLL): Indications for the Therapeutic Use of VEGF-Signaling Inhibitors.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only